Significant Ownership of Dauntless Investment Group, LLC

Signature - Title
/s/Matthew Okkerse - CFO
Location
Milford, MI
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Dauntless Investment Group, LLC.

Notify me when Dauntless Investment Group, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Dauntless Investment Group, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FEMY FEMASYS INC Common 9.9% $1,549,149 +$1,045,272 4,395,996 +207% Dauntless Investment Group, LLC 30 Sep 2025
AEON AEON Biopharma, Inc. Common 9.7% $44,372 108,224 Dauntless Investment Group, LLC 26 Feb 2025
OKYO OKYO Pharma Ltd Common 1.2% $1,466,437 -$6,066,133 471,523 -81% Dauntless Investment Group, LLC 31 Dec 2025
KZIA KAZIA THERAPEUTICS LTD American Depository Shares 0% 1 -100% Dauntless Investment Group, LLC 31 Dec 2025

Schedules 13D/G Reported by Dauntless Investment Group, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.